SEC Form 4 · accession 0002123843-26-000008
Rani Therapeutics Holdings, Inc. · RANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alireza Javadi
Officer — Chief Technical Officer
Period of report
Mar 27, 2026
Accepted (ET)
Jul 21, 2026 · 7:24 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001856725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Mar 27, 2026 | S | 386 | $0.78 | D | 9,689 | D | |
| Class A Common StockF1 | Jun 27, 2026 | F | 309 | $0.74 | D | 9,380 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction is being reported late due to inadvertent administrative oversight.
- F2Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units.
- F3Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units.